New chemical modification reduces off-target effects in siRNA drugs

Small interfering RNA (siRNA) drugs are a class of therapeutic agents that silence specific genes associated with inherited diseases.

Bariatric Surgery in MASH Patients Improved Long-Term Outcomes

Bariatric surgery significantly reduced long-term risk for decompensation and adverse outcomes in patients with obesity and compensated metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis, according to an

January 28, 2025

FTC’s Final Rule Amendment to the Health Breach Notification Rule and Its Implications | Psychedelic Invest

On April 26, 2024, the Federal Trade Commission (FTC) issued a significant final rule amending its Health Breach Notification Rule (HBN Rule). This amendment aims

May 31, 2024

Tufts’ new ingestible microbiome sampling pill completes preclinical trials

Significant progress has been made at Tufts University School of Engineering in the development of a small device, about the size of a vitamin pill,

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.